Is It Too Late to Buy Amphastar Pharmaceuticals Inc (AMPH) After 5.2% Rally? GF Value Says Undervalued

gurufocus.com · 2026-09-25

On September 24, 2026, Amphastar Pharmaceuticals Inc (AMPH) shares rose 5.2% today, trading at $26.27. The stock is currently within a 52-week range of $16.65 t

TickrTrends take: Amphastar Pharmaceuticals has recently gained 5% in price, yet TickrTrends currently assesses the stock as undervalued, suggesting the recent rally may not have fully corrected the valuation gap. For investors focused on valuation metrics in the Healthcare sector, the persistence of an undervalued rating despite the price movement indicates that fundamental value may still exceed current market pricing. Valuation-focused readers should monitor whether further price appreciation aligns with closing this valuation gap or if the stock remains disconnected from intrinsic value estimates.

Read the full story at gurufocus.com →